Activity

Filter

Cancel
Date Panel Item Activity
8 actions
Arthrogryposis v0.217 SCN1A Zornitza Stark edited their review of gene: SCN1A: Changed phenotypes: Dravet syndrome, MIM# 607208, Arthrogryposis multiplex congenita
Arthrogryposis v0.217 SCN1A Zornitza Stark edited their review of gene: SCN1A: Changed phenotypes: Dravet syndrome, MIM# 607208
Arthrogryposis v0.217 SCN1A Zornitza Stark Phenotypes for gene: SCN1A were changed from Arthrogryposis multiplex congenita to Arthrogryposis multiplex congenita; Dravet syndrome, MIM# 607208
Arthrogryposis v0.216 SCN1A Zornitza Stark Marked gene: SCN1A as ready
Arthrogryposis v0.216 SCN1A Zornitza Stark Gene: scn1a has been classified as Green List (High Evidence).
Arthrogryposis v0.216 SCN1A Zornitza Stark Classified gene: SCN1A as Green List (high evidence)
Arthrogryposis v0.216 SCN1A Zornitza Stark Gene: scn1a has been classified as Green List (High Evidence).
Arthrogryposis v0.215 SCN1A Zornitza Stark gene: SCN1A was added
gene: SCN1A was added to Arthrogryposis. Sources: Literature
Mode of inheritance for gene: SCN1A was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: SCN1A were set to 32928894; 29543227
Phenotypes for gene: SCN1A were set to Arthrogryposis multiplex congenita
Review for gene: SCN1A was set to GREEN
Added comment: Note SCN1A is a well-established cause of Dravet syndrome, MIM# 607208
-----
PMID: 32928894 (2020) - De novo missense variants in SCN1A (p.Leu893Phe, p.Ala989Thr, p.Ile236Thr) were identified in three unrelated patients with AMC which was diagnosed from the second trimester of pregnancy. One patient developed intractable epilepsy from birth and died at 21 days, while the other two pregnancies were terminated.

Note we have reported this association previously in PMID 29543227 (Supplementary info) in an infant presenting with AMC and severe EE, and de novo p.(Ile1347Asn) variant which at the time was thought to only partially explain the phenotype, but in light of this new report, likely fully explains the phenotype. Given the presence of severe seizure disorder in the two infants who were phenotype in the newborn period, this likely represents the severe end of the spectrum of SCN1A-related disorders rather than a distinct association.
Sources: Literature